Incisionless Surgeries: Envisioning The Future of Surgical Technology

Global market demand for technologies driving better balance between procedural value and volumes of incisionless surgeries

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer. Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology2.0 Key Findings2.1 Key Findings: Increasing Pressure on Hospitals to Reduce Complexities Associated with Insurance/Medicare Claims2.2 Key Findings: Competitors Focus on Developing Technologies that Enable Hospitals Balance Procedural Value and Volume3.0 Industry Snapshot3.1 Adoption of advanced data analytics help hospitals streamline claims, procedures and turnaround time3.2 The Global Market is Largely Dominated by Interventions for Cancer Diagnosis and Treatment3.3 Intensity of Competitor Presence is Higher in Transoral, Transesophageal and Transluminal Procedures3.4 Incisionless Procedures for Hearing Disorders is a Niche that Commands Higher Premium for Prescribed Procedures3.5 Laminectomy and spine fusion procedures for treating stenosis cost much higher than other incisionless procedures3.6 Global MedTech companies aggressively invest in early stage companies holding innovative IP in incisionless procedures3.7 Flexibility, portability, precision and sensitivity of disease detection are factors differentiating products in the market3.8 Lawsuit claims for transvaginal mesh impose pressure on industry players to invest in new polymer alternatives for vaginal mesh3.9 Transluminal stents from Boston Scientific is likely to disrupt the global market, especially in the USA3.10 Ease of access to incisionless procedures and associated costs of hospitalization impact value of care served by hospitals3.11 Robotic surgical procedures have demonstrated better value to patients undergoing incisionless surgeries, but costs remain high3.12 Use of Polyurethane instead of Polypropylene has been scientifically evaluated to deliver better performance of transvaginal mesh3.13 Technology developments in transurethral procedures are focused towards treatment of benign prostatic hyperplasia (BPH)3.14 Shear Wave Elastography (SWE) Ultrasound has been tested to be non-invasive and less expensive painless imaging technique4.0 Procedural Volumes Vs. Value4.1 Invasive procedures are likely to cost higher and are largely covered through reimbursements4.2 Wireless and contact-free wearable remote monitoring of vital signs enable old age patients to better manage prognosis and reduce hospital re-admissions4.3 Higher demand for deep learning and big data analytics solutions to manage procedural volumes across busy care facilities4.4 Machine learning algorithms have been demonstrated to improve productivity of hospitals by better prioritization of patients for procedures4.5 Liquid biopsy and contact-free patient monitoring are proving to enable hospitals perform precise and accurate diagnosis4.6 Use of handheld robotic laparoscopic surgical instrument enables hospitals balance both procedural volumes and value served5.0 Technology-centric Business Models5.1 Use of recurrent neural networks in critical care facilities enables providers to manage higher procedural volumes5.2 Use of intravenous indocyanine green to differentiate tumor cells has been clinically tested to be safe and effective in cancer diagnosis5.3 Use of hand-held laparoscopic microsurgical instruments serve to be a cost-effective alternative to traditional robotic surgical systems6.0 Patent Analysis6.1 Transurethral procedures as a market segment holds very high granted and applied patents worldwide6.2 Key Patent: Transoral Endoscopic Surgery of Upper Gastrointestinal Tract6.3 Key Patent: Methods and Procedures for Manipulation of Overian Tissues for better Infertility treatment value6.4 Key Patent: Using Camera for Ultrasound Imaging & Proper Transesophageal Echocardiography Probe7.0 Database of Key Industry Contacts7.1 List of Key Industry Contacts7.1 List of Key Industry Participants (continued)Legal Disclaimer

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.